51211000001105: Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)
\UK product\Virtual medicinal product\Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository\Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)
\UK product\Virtual therapeutic moiety\Mesalazine\Product containing only mesalazine in rectal dose form (medicinal product form)\Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository\Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)
\UK product\Virtual therapeutic moiety\Mesalazine\Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository\Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)
\UK product\Trade family\Asacol\Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)

\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing salicylate\Product containing mesalazine\Mesalazine\Product containing only mesalazine in rectal dose form (medicinal product form)\Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository\Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing salicylate\Product containing mesalazine\Mesalazine\Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository\Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing salicylate\Product containing mesalazine\Product containing mesalazine in rectal dose form (medicinal product form)\Product containing only mesalazine in rectal dose form (medicinal product form)\Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository\Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing amino acid derivative\Product containing mesalazine\Mesalazine\Product containing only mesalazine in rectal dose form (medicinal product form)\Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository\Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing amino acid derivative\Product containing mesalazine\Mesalazine\Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository\Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing amino acid derivative\Product containing mesalazine\Product containing mesalazine in rectal dose form (medicinal product form)\Product containing only mesalazine in rectal dose form (medicinal product form)\Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository\Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing phenol structure (product)\Product containing mesalazine\Mesalazine\Product containing only mesalazine in rectal dose form (medicinal product form)\Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository\Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing phenol structure (product)\Product containing mesalazine\Mesalazine\Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository\Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing phenol structure (product)\Product containing mesalazine\Product containing mesalazine in rectal dose form (medicinal product form)\Product containing only mesalazine in rectal dose form (medicinal product form)\Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository\Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)
\Medicinal product\Product manufactured as rectal dose form\Product containing mesalazine in rectal dose form (medicinal product form)\Product containing only mesalazine in rectal dose form (medicinal product form)\Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository\Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

17641301000001110 Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

96937301000001111 Asacol 250mg suppositories (Allergan Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)	Is a	Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository	true	Inferred relationship	Existential restriction modifier
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)	Has active ingredient	Mesalazine	false	Inferred relationship	Existential restriction modifier
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)	VMP non-availability indicator	Available	false	Inferred relationship	Existential restriction modifier
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)	Has manufactured dose form	Suppository	false	Inferred relationship	Existential restriction modifier
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)	Is a	Asacol	true	Inferred relationship	Existential restriction modifier
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)	Has specific active ingredient	Mesalazine	true	Inferred relationship	Existential restriction modifier
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)	Has dispensed dose form	Suppository	true	Inferred relationship	Existential restriction modifier
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)	Has manufactured dose form	Rectal dose form	true	Inferred relationship	Existential restriction modifier
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)	VMP non-availability indicator	Not available	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd) 20 suppository	Is pack of	False	Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd) 20 suppository	Has AMP	True	Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
17641301000001110	Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
96937301000001111	Asacol 250mg suppositories (Allergan Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module